俄亥俄州

我们是谁

  • 4 月 5, 2022
    肿瘤诊断精准免疫肿瘤学和体细胞靶向合理性（TAPISTRY）平台研究
  • 4 月 5, 2022
    eFT226 对部分晚期实体瘤恶性肿瘤受试者的研究
  • 4 月 5, 2022
    Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck
  • 4 月 5, 2022
    治疗实体瘤患者的 Pembrolizumab 和重组白细胞介素-12
  • 4 月 5, 2022
    治疗寡转移性实体瘤患者的全身疗法与局部巩固疗法
  • 4 月 5, 2022
    S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
  • 4 月 5, 2022
    A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC
  • 4 月 5, 2022
    Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
  • 4 月 5, 2022
    PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors
  • 4 月 5, 2022
    KRAS G12C突变晚期结直肠癌患者MRTX849联合西妥昔单抗与化疗的3期研究（KRYSTAL-10）